Navigation Links
FDA Approves DORIBAX(TM) for the Treatment of Complicated Intra-Abdominal and Complicated Urinary Tract Infections
Date:10/15/2007

and regulations; and trends toward health care cost containment. A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 of Johnson & Johnson's Annual Report on Form 10-K for the fiscal year ended December 31, 2006. Copies of this Form 10-K, as well as subsequent filings, are available online at http://www.sec.gov or on request from Johnson & Johnson. The Company does not undertake to update any forward-looking statements as a result of new information or future events or developments.]

For more information on Johnson & Johnson, please visit http://www.jnj.com.

(1) Gram-negative indicates a group of bacteria that become red when the

bacterial cells are treated using the Gram stain method. This response

is based on the chemical and physical properties of their cell walls

and is used to identify the type of bacteria. Some Gram-negative

bacteria may cause serious infections.

(2) Gram-positive indicates a group of bacteria that become blue when the

bacterial cells are treated with the Gram stain. This response is

based on the chemical and physical properties of their cell walls and

is used to identify the type of bacteria. Some Gram-positive bacteria

may cause serious infections.


'/>"/>
SOURCE Ortho-McNeil, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. UW-Madison approves new research institute
2. FDA approves GEs heart-imaging technology
3. Senate approves bill to expand stem cell funding
4. FDA approves advanced digital mammography system
5. Building commission approves Institutes for Discovery
6. UW Board of Regents approves $134 million medical research facility
7. FDA approves Bone Cares Hectorol for treatment of kidney disease
8. Unique Surface Treatment of Novel TSK-GEL ODS Columns Provide Separation of Aqueous and Fat Soluble Vitamins
9. Improve Recovery and Reproducibility with Pre-Treatment of Analytical TSK-GEL G3000SWXL Size Exclusion Columns
10. Quintessence cancer treatment chosen for clinical studies
11. ZyStor to exhibit cell disorder treatments
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):MSU research may lead to new ways to control honeybee parasite 2Studying hair of ancient Peruvians answers questions about stress 2BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 2BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 3Olympic Gold Medalist World Cup Champion and Soccer Hall of Famer Joy Fawcett Sports A New Uniform as an Official Cuties 28R 29 California Mandarin a 62344 1Olympic Gold Medalist World Cup Champion and Soccer Hall of Famer Joy Fawcett Sports A New Uniform as an Official Cuties 28R 29 California Mandarin a 62344 2Olympic Gold Medalist World Cup Champion and Soccer Hall of Famer Joy Fawcett Sports A New Uniform as an Official Cuties 28R 29 California Mandarin a 62344 3Olympic Gold Medalist World Cup Champion and Soccer Hall of Famer Joy Fawcett Sports A New Uniform as an Official Cuties 28R 29 California Mandarin a 62344 4Medicare Administrator Establishes Reimbursement Coding Policy for Agendias Breast Cancer Recurrence Test MammaPrint 28R 29 15018 1Medicare Administrator Establishes Reimbursement Coding Policy for Agendias Breast Cancer Recurrence Test MammaPrint 28R 29 15018 2Medizone International Takes Aim at the Bioterrorism Countermeasures Arena 15015 1Medizone International Takes Aim at the Bioterrorism Countermeasures Arena 15015 2